Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models

Development of personalized cancer vaccines based on neoantigens has become a new direction in cancer immunotherapy. Two forms of cancer vaccines have been widely studied: tumor-associated antigen (including proteins, peptides, or tumor lysates)-pulsed dendritic cell (DC) vaccines and protein- or pe...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Immunol Immunother
Glavni autori: Zhang, Rui, Yuan, Fengjiao, Shu, Yang, Tian, Yaomei, Zhou, Bailing, Yi, Linglu, Zhang, Xueyan, Ding, Zhenyu, Xu, Heng, Yang, Li
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2019
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6949210/
https://ncbi.nlm.nih.gov/pubmed/31807878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-019-02448-z
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items